(Q44748165)

5 December 2017

Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis (English)

1 reference

5 December 2017

0 references

1 reference

Yuji Kato

1

1 reference

5 December 2017

Satoshi Yamaguchi

2

1 reference

5 December 2017

Sunao Yachiku

3

1 reference

5 December 2017

Shusaku Nakazono

4

1 reference

5 December 2017

Jun-ichi Hori

5

1 reference

5 December 2017

Naoki Wada

6

1 reference

5 December 2017

Kyokushin Hou

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

63

1 reference

5 December 2017

1

1 reference

5 December 2017

7-11; discussion 11-2

1 reference

Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

The role of magnesium in calcium oxalate urolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Influence of magnesium on the absorption and excretion of calcium and oxalate ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Physicochemical action of potassium-magnesium citrate in nephrolithiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Potassium-magnesium citrate versus potassium chloride in thiazide-induced hypokalemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Long-term treatment of calcium nephrolithiasis with potassium citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis--a prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

Urine composition in patients with urolithiasis during treatment with magnesium oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2003.09.057

10.1016/J.UROLOGY.2003.09.057

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference